The Triumph of Biotechnology and Private Capital | WHAT REALLY HAPPENED X-Frame-Options: DENY X-Frame-Options: SAMEORIGIN

The Triumph of Biotechnology and Private Capital

We continue to fight COVID-19 and its variants, but the rapid development of vaccines last year put us on the offensive against the disease. Vaccines from Moderna of Massachusetts and BioNTech of Germany have led the way, with 360 million doses delivered in the United States to date. (BioNTech teamed with Pfizer for the manufacturing and distribution of its shot.)

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA